CAPRICOR THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $22.3 | $25.2 | $2.6 | $0.2 |
| Operating income | -$108.1 | -$42.6 | -$24.1 | -$29.7 | -$20.9 |
| Net income | -$105.0 | -$40.5 | -$22.3 | -$29.0 | -$20.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$72.7 | -$41.2 | -$26.9 | $2.9 | -$18.0 |
Shares outstanding 58.1M · Free float 42.5%
Annual filing data through FY ended December 31, 2025; float as of September 9, 2026.